Overall, the identified IDH1 and TP53 mutations, the lack of molecular alterations seen in primary GBM and the longest survival of the study indicate this case is an IDH mutant form of GBM, often referred to as “secondary GBM”. This evidence concerns the gene IDH1 and glioblastoma.